O&G SAQs · Antenatal care — fetal surveillance
Fetal Dopplers in early-onset FGR — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on early-onset fetal growth restriction with severe umbilical artery Doppler abnormality: initial assessment, the four Doppler vessels and what each tells you, the TRUFFLE delivery logic, and prognostic counselling. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: named vessels, named thresholds, the TRUFFLE delivery triggers and the reasoning that distinguishes a delivery vessel from a surveillance vessel. Write in short labelled points. [1][5]
Reveal model answer and mark schemeShowHide
(a) Initial assessment and immediate management (4 marks)
- Confirm the diagnosis and severity: EFW on the 3rd centile, UA-PI above the 95th centile, absent end-diastolic flow (AEDF) — this is severe early-onset fetal growth restriction with critical placental disease.
- Admit for inpatient surveillance with daily to alternate-day umbilical artery, middle cerebral artery, ductus venosus Doppler and computerised CTG short-term variation; continuous CTG if any concern.
- Administer corticosteroids for fetal lung maturation (betamethasone or dexamethasone) and magnesium sulfate for neuroprotection if delivery before 32 weeks is being considered.
- Assess the mother for pre-eclampsia: blood pressure 138/88 with early-onset FGR is concerning; check urine protein, bloods, and arrange senior review — the TRUFFLE insights paper notes that most women with early-onset FGR develop hypertension.[2]
(b) Doppler surveillance and what each vessel tells you (4 marks)
One mark per vessel with what it tells you. [1][5]
| Vessel | What it tells you | Abnormal = |
|---|---|---|
| Umbilical artery | Placental impedance | AEDF (here), REDF — the placenta in a waveform |
| Middle cerebral artery | Cerebral redistribution (brain-sparing) | MCA-PI below the 5th centile — compensation, not endpoint |
| Ductus venosus | Cardiac compromise, central venous pressure | Absent or reversed a-wave — late-stage decompensation |
| Uterine artery | Trophoblastic invasion (already abnormal here) | High PI with bilateral notching — failed placentation |
The sequence of deterioration is predictable: umbilical artery first, MCA second, ductus venosus last. The cerebroplacental ratio (MCA-PI divided by UA-PI) is a derived index that captures brain-sparing. [5]
(c) TRUFFLE-informed delivery logic (4 marks)
One mark per element with reasoning. [1][2][3]
- The TRUFFLE trial (Lees, Lancet 2015) randomised early-onset FGR at 26 to 32 weeks to delivery based on reduced cCTG short-term variation, early DV change (DV-PI above the 95th centile), or late DV change (absent or reversed a-wave). Among survivors, the late-DV group had the best 2-year neurodevelopmental outcome (95% free of neuroimpairment versus 85% for cCTG alone, p=0.005).[1]
- Deliver on late DV change or abnormal cCTG short-term variation (below the gestation-specific TRUFFLE cutoff).[1]
- Do NOT deliver on cerebral Doppler changes alone — cerebral redistribution (low MCA-PI) is a compensation, not an endpoint (TRUFFLE insights, Frusca 2018).[2]
- The combined GRIT/TRUFFLE analysis (Ganzevoort 2020) showed that cCTG plus DV Doppler gave the best 2-year survival without impairment (84%, 95% CI 80 to 89%).[3]
(d) Counselling on prognosis and recurrence (3 marks)
- Prognosis: AEDF and especially REDF carry the highest risk of perinatal mortality and long-term neurodevelopmental impairment; counsel honestly about the risks of prematurity (delivery likely by 32 to 34 weeks) and the 1% cerebral palsy rate seen in TRUFFLE.[2]
- Recurrence: counsel on the increased risk of FGR, pre-eclampsia and stillbirth in future pregnancies and the role of first-trimester aspirin prophylaxis (150 mg nocte from 12 weeks for high-risk women).[6]
- Placental histology at delivery to confirm the aetiology (maternal vascular malperfusion) and inform counselling and the plan for next time.
References5ShowHide
- [1]Lees CC, Marlow N, van Wassenaer-Leemhuis A, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial Lancet, 2015.PMID 25747582
- [2]Frusca T, Todros T, Lees C, Bilardo CM; TRUFFLE Investigators Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe Am J Obstet Gynecol, 2018.PMID 29422211
- [3]Ganzevoort W, Thornton JG, Marlow N, et al. Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials Ultrasound Obstet Gynecol, 2020.PMID 31125465
- [5]Lees CC, Stampalija T, Baschat AA, et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction Ultrasound Obstet Gynecol, 2020.PMID 32738107
- [6]Martins JG, Biggio JR, Abuhamad A Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction Am J Obstet Gynecol, 2020.PMID 32407785